A multicenter team including Endeavor Health and Eli Lilly found that once-weekly eloralintide produced dose-dependent weight loss up to 20% over 48 weeks in adults with obesity or overweight without type 2 diabetes.
Source: Medical Xpress
Once-weekly eloralintide leads to 20% weight loss in Phase II trial
Contact Dr. Alatassi
Endeavor Health Medical Group
8 Salt Creek Lane
Hinsdale, IL 60521
Hinsdale, IL 60521
Mon - Fri : 09.00 am - 06.00 pm
Sat - Sun : Closed
Sat - Sun : Closed
TeleSlim Clinic Texas
708 Main Street
10th Floor
Houston, TX 77002
10th Floor
Houston, TX 77002
[javascript protected email address]
